- Home
- ZLAB vs KC Comparison
ZLAB vs KC Comparison
Compare ZLAB & KC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- KC
- Stock Information
- Founded
- ZLAB 2013
- KC 2012
- Country
- ZLAB China
- KC China
- Employees
- ZLAB N/A
- KC N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- KC Computer Software: Prepackaged Software
- Sector
- ZLAB Health Care
- KC Technology
- Exchange
- ZLAB Nasdaq
- KC Nasdaq
- Market Cap
- ZLAB 3.4B
- KC 3.6B
- IPO Year
- ZLAB 2017
- KC 2020
- Fundamental
- Price
- ZLAB $33.78
- KC $20.67
- Analyst Decision
- ZLAB Strong Buy
- KC Strong Buy
- Analyst Count
- ZLAB 3
- KC 7
- Target Price
- ZLAB $55.00
- KC $5.69
- AVG Volume (30 Days)
- ZLAB 752.8K
- KC 5.3M
- Earning Date
- ZLAB 02-27-2025
- KC 03-19-2025
- Dividend Yield
- ZLAB N/A
- KC N/A
- EPS Growth
- ZLAB N/A
- KC N/A
- EPS
- ZLAB N/A
- KC N/A
- Revenue
- ZLAB $355,748,000.00
- KC $1,037,206,927.00
- Revenue This Year
- ZLAB $49.04
- KC $11.30
- Revenue Next Year
- ZLAB $46.80
- KC $12.29
- P/E Ratio
- ZLAB N/A
- KC N/A
- Revenue Growth
- ZLAB 35.01
- KC N/A
- 52 Week Low
- ZLAB $13.48
- KC $2.02
- 52 Week High
- ZLAB $36.60
- KC $22.26
- Technical
- Relative Strength Index (RSI)
- ZLAB 79.95
- KC 70.52
- Support Level
- ZLAB $30.61
- KC $18.65
- Resistance Level
- ZLAB $33.00
- KC $22.26
- Average True Range (ATR)
- ZLAB 1.32
- KC 1.45
- MACD
- ZLAB 0.58
- KC 0.29
- Stochastic Oscillator
- ZLAB 86.34
- KC 79.32
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About KC Kingsoft Cloud Holdings Limited
Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Safety, database, AI, hybrid cloud and others. Its solutions are medical, government affairs, finance, media, Educate, game, Transportation and Logistics, Audio, and video.